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Scaffolds derived from natural polysaccharides are very promising in tissue engineering applications and re-
generative medicine, as they resemble glycosaminoglycans in the extracellular matrix (ECM). In this study, we
have prepared freeze-dried composite scaffolds of chitosan (CHT) and hyaluronic acid (HA) in different weight
ratios containing either no HA (control) or 1%, 5%, or 10% of HA. We hypothesized that HA could enhance
structural and biological properties of CHT scaffolds. To test this hypothesis, physicochemical and biological
properties of CHT/HA scaffolds were evaluated. Scanning electron microscopy micrographs, mechanical
properties, swelling tests, enzymatic degradation, and Fourier transform infrared (FTIR) chemical maps were
performed. To test the ability of the CHT/HA scaffolds to support chondrocyte adhesion and proliferation, live–
dead and MTT assays were performed. Results showed that CHT/HA composite scaffolds are noncytotoxic and
promote cell adhesion. ECM formation was further evaluated with safranin-O and alcian blue staining methods, and
glycosaminoglycan and DNA quantifications were performed. The incorporation of HA enhanced cartilage ECM
production. CHT/5HA had a better pore network configuration and exhibited enhanced ECM cartilage formation.
On the basis of our results, we believe that CHT/HA composite matrixes have potential use in cartilage repair.
Introduction
Cartilage damage frequently occurs because of sportsor progressive ageing. Once damaged, cartilage cannot
be spontaneously repaired because of its avascularity and
low cellular mitotic activity.1 A range of clinical options
emerged to repair focal lesions and damage to the articular
surface. These approaches may reduce pain and increase
mobility, but only to a limited extent and over a short-term
period.2,3 Current strategies are not able to fully restore the
native structure of cartilage, which raises concerns about the
long-term performance of repaired cartilage.4 These partial
successes lead to significant research efforts to develop tissue
engineering therapies for cartilage repair.
The main challenge for cartilage tissue engineering is the
chondrocytes massive transition into fibroblastic cells during
the in vitro culture process. Those dedifferentiated cells form
fibrocartilage instead of hyaline cartilage.5 Additionally,
chondrocytes availability is limited because of the size of
biopsies that can be collected from the patient’s own tissue,
without causing the risk of morbidity of the site of explant.
Moreover, the development of biodegradable polymers to
perform the role of a temporary matrix is an important factor
in the success of cell transplantation.6,7
Extracellular matrices (ECMs) provide a microenviron-
ment for cells to maintain homeostasis and to retain the re-
quired differentiated state for specific tissues.8 Among the
many different ECM molecules, hyaluronic acid (HA) is the
main glycosaminoglycan (GAG) in the mesenchyme during
the early stage of chondrogenesis.9,10 In addition, HA is
known to influence chondrocytes by triggering a sophisti-
cated signaling pathway leading to enhancement of cellular
functions.11,12 However, the concentration of HA must be
confined to a relatively low amount, as concentrations may
reduce cell adhesion because of its negative charge.13 This
disadvantage can be overcome by combining HA with pos-
itively charged polycations such as chitosan (CHT).14 CHT, a
partially deacetylated derivative from chitin, has the ability
to interact with negatively charged molecules.15 Because of
its biocompatibility and biodegradability, CHT has been
widely applied in tissue engineering strategies.16–19 Ad-
ditionally, CHT is structurally similar to various GAGs
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found in articular cartilage.20 Combining the advantages of
both polysaccharides, CHT/HA scaffolds can be suitable
candidates for cartilage tissue regeneration. The blend would
be stabilized by an ionic interaction between the positively
charged CHT and the negatively charged HA.
CHT has been already conjugated with HA to obtain a
biomimetic matrix for chondrocytes.16,21–24 Yamane et al.22
developed CHT-based HA polymer fibers by the wetspin-
ning method. In the hybrid fibers, chondrocyte adhesion,
proliferation, and also the synthesis of aggrecan and type II
collagen were significantly higher when compared with
CHT fibers. Hsu et al.24 studied CHT–alginate–hyaluronan
scaffolds, with or without covalent attachment, with RGD-
containing protein. The cell-seeded scaffolds showed neo-
cartilage formation in vitro in the presence or absence of
RGD. Tan et al.21 demonstrated that CHT-HA hydrogels al-
lowed cell survivor, and cells retained the chondrogenic
morphology.
The reported studies are focused on the superior biological
effects that HA could provide, and its incorporation has not
been studied in terms of physicochemical effects. Ad-
ditionally, to our knowledge, the effect of varying the ratio
between CHT and HA, and consequently, its influence in
terms of both physicochemical and biological properties, has
not been yet reported. On the other hand, because of HA
high water uptake and the lack of mechanical strength pro-
vided by natural polymers, the existing strategies combining
CHT and HA for cartilage tissue engineering are very limited
and usually consist in hydrogels.21,25 However, these hy-
drogels do not have the required mechanical strength to
maintain the initial shape of the implanted scaffold. Conse-
quently, they cannot be transplanted into large cartilaginous
lesions in advanced degenerative diseases, such as osteoar-
thritis and rheumatoid arthritis. Moreover, the existing
CHT/HA blends are usually used to produce scaffolds by
techniques more complex than the freeze-drying method, in
which further research is needed to determine the adequate
shape, pore size, and mechanical properties of a three-
dimensional fabrication for cartilage TE.
The aim of this work was to prepare a new class of hybrid
scaffolds composed of CHT as a framework containing low
concentrations of HA to mimic cartilage ECM composition.
The application of HA as a component of the cartilage scaf-
fold biomaterial could be a reasonable approach for en-
hancing chondrogenesis. We hypothesized that HA could
provide superior effects on the formation and structural and
biological properties of CHT scaffolds, by providing a suit-
able microenvironment where chondrocytes may produce a
cartilage-specific matrix for cartilage regeneration. To test
this hypothesis, HA was added to CHT solution in a final
polymer concentration of 2% (w/v) to prepare three-
dimensional scaffolds by freeze-drying method.19 Using this
method, porous scaffolds are easily prepared with control-
lable pore size, uniform pore distribution, and functional
features. Four types of scaffolds were obtained containing
either no HA (control, CHT) or 1% (CHT/1HA), 5% (CHT/
5HA), and 10% of HA (CHT/10HA). The physicochemi-
cal properties and biological behavior of the developed
scaffolds were evaluated to study the HA influence in the
CHT scaffolds in different parameters, including pore size




Medium-molecular-weight CHT (Mw: 190,000–310,000,
75%–85% deacetylation degree, viscosity: 200–800 cps) and
HA (#81, Lot Dev 00453, Mw: 1.8 million) were purchased
from Sigma-Aldrich. Before being used, CHT was purified by
recrystallization. CHT was dissolved in 1% (w/v) acetic acid
solution and then filtered under vacuum through porous
membranes (Whatman ashes filter paper, 20–25mm) into a
Buckner flask. By adding a solution of sodium hydroxide, the
pH of the solution was adjusted to 8, resulting in flocculation
due to deprotonation and insolubility of the polymer at neu-
tral pH. The polymer solution was then neutralized until the
pH was equal to that of distilled water. Samples were frozen
at -80C and lyophilized. Lysozyme from chicken egg white
(lyophilized powder, *100,000 U/mg, stored at 4C) and
hyaluronidase from bovine tests (Type VIII, 300 U/mg, stored
at - 20C) were purchased from Sigma-Aldrich.
Methods
Preparation of CHT and HA scaffolds. CHT and HA
were first separately dissolved (1%, w/v) overnight at room
temperature in diluted acetic acid (1%, v/v) and subsequently
mixed in different ratios (w/v) in a final polymer concentration
of 2% (w/v). To obtain a cylindrical shape, the polymeric so-
lutions were placed into plastic tubes and frozen for 1 day at
- 80C. The plastic tubes were then cut into small pieces to
obtain a scaffold dimension of 5 mm·Ø 6 mm. After freeze-
drying, the scaffolds were neutralized with a solution of NaOH
(0.1 M) and then freeze-dried again. Four types of scaffolds
were obtained, containing 0% (control), 1%, 5%, or 10% of HA
(CHT; CHT/1HA; CHT/5HA; and CHT/10HA, respectively).
Physicochemical characterization. Morphology and pore
size: The morphology of CHT/HA scaffolds was character-
ized by scanning electron microscopy (SEM). The scaffolds
were gold-coated using a sputter coater (Cressington) for 60 s
at a current of 40 mA. Cross-sectional morphologies were
viewed using a Philips XL 30 ESEM-FEG operated at 10 kV
accelerating voltage. Pore size was measured using a sub-
menu, consisting on a ruler tool, incorporated in the software
of the SEM equipment. Once the overall cross-sectional im-
ages of the scaffolds were obtained, several pores (> 20) were
selected. In each selected pore, the ruler tool measured the
diameter of the pore by measuring the distance between two
points. In each cross-sectional image of the scaffolds, the
average pore size was calculated.
Fourier transform infrared spectroscopy imaging measure-
ments: To confirm the presence of chitosan or hyaluronic acid
in the different scaffold’s formulations, Fourier transform
infrared (FTIR) measurements were performed using a Per-
kin-Elmer Spectrum Spotlight 200 FTIR Microscope System
in reflectance mode. As a monochromotic light beam reaches
the sample, subsequently, the light reflected is measured for
different wavelengths. The reflected light at a determined
wavelength is characteristic for each functional group, thus it
can be identified, confirming its presence in the sample
analyzed. The four scaffold formulations and a sample of
pure HA were analyzed without further modifications in
the range of 720–1800 cm- 1. The selected region for CHT
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identification was 1650 cm - 1, which corresponds to C=O
stretching of amide I.26 The selected region for HA was
1045 cm-1, which corresponds to C-O-C bond stretching vi-
bration of symmetric ester band.27,28 To obtain the chemical
maps, a submenu incorporated in the software of the FTIR
equipment was used. Two ranges and three colors were se-
lected. For CHT, the range 1630–1670 cm-1 integrates the
amide I characteristic peak and it is represented in green. For
HA, the range 1025–1065 cm-1 integrates the ester character-
istic peak and it is represented in red. The color yellow was
selected to represent the presence of the two characteristic
peaks simultaneously. Spectra were collected in continuous
scan mode for sample areas of 85· 85mm2, with a spectral
resolution of 16 cm-1 by averaging 15 scans for each spectrum.
Mechanical properties: Mechanical compression tests of the
scaffolds were performed using an INSTRON 5543 (Instron
Int. Ltd.) up to 60% of strain, at room temperature. The
testing machine was equipped with a 1 kN load cell and the
loading rate was 2 mm/min. The compressive modulus was
calculated in the initial linear section of the stress–strain
curve, when the strain was lower than 10%. The mechanical
properties of the scaffolds were tested in both dry and wet
states. In the wet state assay, scaffolds were immersed in
phosphate-buffered saline (PBS) at pH 7.4 for 24 h in a
shaking water bath at 37C to simulate in vivo conditions and
for complete hydration. Compressive mechanical tests were
performed in n = 6 per scaffold formulation in both assays.
Swelling properties: The water sorption capacity of the
scaffolds was determined by swelling of freeze-dried scaf-
folds (with known weights) in PBS (Gibco) at pH 7.4 for 3
days at 37C. The swollen scaffolds were removed at pre-
determined time intervals (15 min, 30 min, 1 h, 2 h, 4 h, 6 h,
8 h, 24 h, 2 days, and 3 days) and immediately weighed with
an analytical balance (Scaltec) after the removal of excess of
water by keeping the surfaces on a filter paper (Whatman
Pergamyn Paper, 100 · 100 mm). The swelling ratio (SR) was
calculated using the following equation (1):
SR¼ (WwWd)=Wd (1)
where Ww and Wd are the weights of the scaffolds at the
swelling state and the dry state, respectively.
Enzymatic degradation: CHT/HA scaffolds were placed at
pH 7.4 in PBS (control) or at pH 7.11 in an enzymatic solution
containing 2 mg/mL of lysozyme29 and 0.33 mg/mL of hy-
aluronidase30 in a shaking water bath at 37C. The medium
was replaced every third day. At predetermined time inter-
vals (7 and 14 days), scaffolds were taken from the solutions
and washed with distilled water three times to remove salts.
The weight was measured after the scaffolds were immersed
in 100% ethanol for 2 h and dried for 1 day at room tem-
perature. The percentage weight loss (%WL) of scaffolds was
calculated according to the following equation (2):
%WL¼ [(WiWf)=Wi] · 100% (2)
where Wi is the initial dry weight of scaffold and Wf is the
weight of the dry scaffold after incubation in the PBS or
enzymatic solution.
Bovine articular chondrocyte culture. Bovine articular
chondrocytes were isolated from freshly collected cartilage
from a calf knee through enzymatic digestion, under sterile
conditions. Briefly, cartilage was minced in small pieces,
which were incubated overnight in Dulbecco’s modified
Eagle’s medium (DMEM) with 0.2% collagenase II (Wor-
thington). Afterward, cells were washed with PBS (Gibco)
and resuspended in chondrocyte proliferation medium con-
taining DMEM high glucose (Invitrogen), fetal bovine serum
(10%; Sigma-Aldrich), nonessential amino acids (0.1 mM;
Sigma-Aldrich), penicillin/streptomycin (100 U/100 mg/mL;
Invitrogen), proline (0.4 mM; Sigma-Aldrich), and Asap
(0.2 mM; Invitrogen). Ultimately, cells were seeded in plastic
tissue culture flasks and incubated in a humidified atmo-
sphere with 5% CO2 at 37C. Adherent chondrocytes were
expanded and the medium was changed every third day,
until the cells achieved 80% confluence.
Prior to cell seeding, the scaffolds were sterilized with 70%
(v/v) ethanol for 2 h, rinsed three times in distilled water,
and then immersed in PBS for 2 days. The seeding was
performed by injection of a cell suspension, on which the cell
concentration was adjusted to 0.5 · 106 cells in 20 mL of me-
dium (per scaffold). After incubation for 4 h at 37C in a 5%
CO2 atmosphere incubator, chondrocyte proliferation me-
dium or chondrocyte differentiation medium [DMEM, 2 mM
glutamax (Gibco), 0.2 mM Asap (Invitrogen), 100mg/mL
penicillin/streptomycin, 0.4 mM proline (Sigma-Aldrich),
100mg/mL sodium pyruvate (Sigma-Aldrich), and 50 mg/
mL ITS +premix (BD biosciences]. Immediately before use,
10 ng/mL TGF-b3 (R&D Systems) and 0.1 mM dexametha-
sone (Sigma-Aldrich) were added to the seeded scaffolds,
according to the type of assay performed.
Biological assays. To analyze cell viability, proliferation,
and adhesion of CHT/HA scaffolds, articular bovine chon-
drocytes were seeded by injection at passage 3 in prolifera-
tion medium. Live/dead and MTT assays were performed at
1, 3, 7, 14, and 21 days, according to manufacturer’s speci-
fications, and scaffolds were further observed by SEM. To
evaluate the chondrogenic phenotype maintenance, articular
bovine chondrocytes were seeded by injection at passage 1 in
differentiation medium. Safranin-O and alcian blue staining
methods, quantitative GAG and DNA assays, and SEM ob-
servation were performed. Chondrocyte medium was chan-
ged every third day to maintain an adequate supply of cell
nutrients.
Live/dead assay: Scaffolds were deposited in a 48-well plate.
To perform this assay, chondrocyte proliferation medium
was aspirated from the wells and the seeded scaffolds were
incubated with ethidium homodimer-1 (6mM) and calcein-
AM (4 mM) (Invitrogen) for 30 min in the dark at 37C in a
5% CO2 atmosphere incubator. Scaffolds were immediately
examined in an inverted fluorescent microscope (Nikon
Eclipse E600) using an FITC/Texas Red Filter. The images
were captured using a color camera (Nikon FDX-35) and the
QCapture software. Calcein-AM is enzymatically converted,
producing fluorescent living cells, as live cells have intra-
cellular esterase activity. Ethidium homodimer-1 is only able
to enter dead cells, and after binding to nuclei acids, a red
fluorescent signal is produced.
MTT assay: Scaffolds were deposited in a 48-well plate and
incubated with 1 mL of chondrocytes proliferation medium
and 20mL MTT solution (5 mg/mL; Gibco) per well for 2 h at
37C in a 5% CO2 atmosphere incubator. MTT is a pale
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yellow substrate, which is reduced by living cells to for-
mazan, which stains dark purple. This process requires ac-
tive mitochondria and is thus an accurate measure of the
metabolic activity of cells in a culture. At the referred time
intervals, MTT solution was added to each well. During this
period, viable cells could reduce the MTT formazan. Images
were captured using a color camera (Nikon SMZ-10A) and
the MATRIX Vison SRGB 32Bit software.
SEM observation: Chondrocytes adhesion on scaffolds was
analyzed by SEM (n= 2). CHT/HA scaffolds were immersed
in 10% (v/v) formalin overnight at 4C. Specimens were then
dehydrated using sequential ethanol series (70%, 80%, 90%,
96%, and 100% (v/v), 1 h in each, and critical point dried
using a Balzers CPD 030 machine. The scaffolds were gold-
sputtered as previously described for further observation by
SEM operated at 10 kV accelerating voltage.
Histology: Safranin-O and alcian blue staining methods
were used to analyze cartilage tissue formation. Scaffolds
were washed with PBS, fixed overnight in 10% formalin,
and then dehydrated using sequential ethanol series [70%,
80%, 90%, 96%, and 100% (v/v), 1 h in each]. Once dehy-
drated, they were incubated in butanol overnight and then
in a solution containing butanol and paraffin (50:50) for 8 h.
Ultimately, the scaffolds were embedded in paraffin and
5-mm-thick sections were cut using a microtome. After de-
paraffinization with xylene and rehydration using a graded
ethanol series [from 100% to 70% (v/v)], the samples were
stained. For safranin-O staining, sections were counter
stained with hematoxylin (Sigma-Aldrich) and fast green
(Merk) to visualize cells and cell nuclei, respectively, and
safranin-O (Sigma-Aldrich) for visualization of GAGs in
red. For alcian blue staining, sections were stained with
alcian blue solution (1% in acetic acid) for 30 min to visu-
alize extracellular GAGs in blue. After the washing steps,
the samples were counterstained with nuclear fast red for
5 min. Slides were assembled with resinous medium and
mounted slides were examined under a light micro-
scope (Nikon Eclipse E600). Representative images were
captured using a digital camera (Nikon FDX-35) and
QCapture software. Each assay was performed at either 1,
14, 21, and 35 days of culture in duplicate (n = 2 per scaffold
formulation).
Quantitative GAG and DNA assays: CHT/HA scaffolds were
washed with PBS and frozen at - 80C for quantitative anal-
ysis of GAG expression and cell number. Subsequently, they
were digested with 1 mg/mL proteinase K (Sigma-Aldrich) in
Tris/EDTA buffer (pH 7.6) containing 18.5mg/mL iodoace-
tamide and 1mg/mL pepstatin A (Sigma-Aldrich) for 20 h at
56C. GAG content was spectrophotometrically determined
with DMMB (Sigma-Aldrich) staining in PBE buffer [PBS
containing 14.2 g/L Na2HPO4 and 3.72 g/L Na2EDTA (pH
6.5)] with a monochromatic microplate reader (TECAN Safire
2) at an absorbance of 520 nm. The standard curve for the
GAG analysis was generated using chondroitin sulfate A
(Sigma-Aldrich). Quantification of total DNA was determined
with the CyQuant DNA kit, according to the manufacturer’s
description (Molecular Probes), using a fluorescent plate
reader (emission: 520 nm; excitation: 480 nm; Perkin-Elmer).
The standard curve for DNA analysis was generated with l
DNA provided with the CyQuant DNA kit. The assays were
performed at 1, 14, 21, and 35 days of culture.
Statistical analysis. Each experiment was carried out in
triplicate unless otherwise specified. All results are presented
as mean – standard deviation (SD). The experimental data
were analyzed using single-factor analysis of variance tech-
nique to assess the statistical significance of results. Statistical
significance was set at a p-value of £ 0.05 (*) or £ 0.01 (**).
Results and Discussion
Physicochemical characterization of CHT
and HA scaffolds
Scaffolds preparation and microstructure observa-
tion. Concentrations of HA-based scaffolds are usually
limited to 2% (w/v), or less, because higher concentrations
FIG. 1. SEM micrographs
for cross section (C) of the
chitosan (CHT) and hya-
luronic acid (HA) scaffolds
prepared, using different
ratios of CHT and HA (n = 3).
The subscripts indicate the
percentage of HA (0%, 1%,
5%, and 10%). C0 arrow evi-
dences the sheet-like areas of
CHT scaffolds. C10 arrow
shows the irregular pore geo-
metry of CHT/10HA scaf-
folds. Original magnification
is · 100 and the scale bar
represents 200 mm. SEM,
scanning electron microscopy.
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are too viscous for adequate mixing.31 The morphologies of
the scaffolds were investigated based on different ratios be-
tween CHT and HA. To characterize the microstructure
morphology of CHT and HA scaffolds, cross-sectional SEM
images were obtained (Fig. 1). CHT scaffolds showed a
closed network pore configuration with sheet-like areas (ar-
row in Fig. 1C0). In contrast, CHT/1HA and CHT/5HA
scaffolds showed a more open network structure. These two
formulations had high porosity and uniformly distributed
pore structures. In CHT/10HA scaffolds, pore geometry
was very irregular with closed or oversized collapsed pores
(arrow in Fig. 1C10). This influence on porosity and pore
structure when HA was incorporated in scaffolds of poly-
cationic polymers was also found by Ren et al.13 The dif-
ferences between the pore architecture are at least partially
related to the homogeneity of the polymeric solution, that
is, how well are the two polymers mixed and dispersed in
the solution. As CHT and HA have an opposite charge, an
ionic bond between the carboxyl groups of HA and the
amino groups of CHT is expected.15 As the concentration of
HA increased in the CHT/HA formulation, the solution
became more opaque. The incorporation of HA up to a
concentration of 5% in a CHT solution yielded a well-
dispersed colloidal suspension. CHT/5HA suspension was
stable, indicating the formation of submicrometer com-
plexes. In contrast, higher concentrations of HA jeopardized
efficient mixture of both polymers, resulting in white pre-
cipitates. These precipitates tended to aggregate and, con-
sequently, after freeze-drying, resulted in a nonuniform
pore geometry (Fig. 1C10). Mao et al.
32 also studied CHT
and HA blends and correlated the formation of white pre-
cipitates with the high density of carboxyl groups in HA
and amino groups in CHT.
Pore size increased with concentrations of HA in CHT
scaffolds (Table 1). Fan et al.31 reported the same influence of
HA on scaffold pore size. CHT/10HA also exhibited the
highest standard deviation in pore sizes because of the
nonuniform pore geometry. The open pore network and a
range in pore size between *77 and 97 mm, as observed in
CHT/1HA and CHT/5HA scaffolds, rendered these scaf-
folds appropriate for cellular infiltration. Particularly, we
hypothesize that articular bovine chondrocytes can be in-
corporated into the aforementioned scaffolds.
Fourier transform infrared spectroscopy imaging mea-
surements. FTIR measurements (Fig. 2) confirmed the
presence of CHT and HA in all CHT/HA scaffolds. Char-
acteristic peaks of both polymers (Fig. 2a) were found,
namely a distinct band at 1650 cm - 1 (amide I) and at
1580 cm- 1 (amide II).26 The ester group (1045 cm- 1), a HA
characteristic peak, is the main difference between the two
spectra. The referred characteristic peaks were also found in
all CHT/HA scaffolds spectra (Fig. 2b). Particularly, CHT/
10HA had a notable higher intensity in the ester peak, as it is
the formulation with higher amount of HA.
The homogeneity of the CHT/HA blends was investi-
gated by FTIR mapping (Fig. 3). As expected, chemical maps
of CHT scaffolds (Fig. 3a) and pure HA (Fig. 3b) only
showed the selected color for the pure materials (green and
red, respectively). As showed in Figure 3d, CHT/5HA
scaffolds had an improved polymer mixture, in which the
two polymers were well dispersed in the length scale ana-
Table 1. Pore Size (mm) and Compressive Modulus (kPa) of the Chitosan/Hyaluronic Acid Scaffolds










in dry state (kPa)
Compressive modulus
in wet state (kPa)
CHT 100 0 55.80– 10.04 291.03 – 82.73 2.84 – 0.41
CHT/1HA 99 1 77.40– 15.01 144.33 – 28.32 2.43 – 0.07
CHT/5HA 95 5 97.43– 6.56 144.00 – 25.68 2.30 – 0.06
CHT/10HA 90 10 148.73– 99.24 40.73 – 18.31 1.21 – 0.47
Values are reported as mean– SD.
FIG. 2. Fourier transform infrared (FTIR) spectra of (a)
CHT scaffolds (solid line) and pure HA (dashed line) and of
(b) CHT/1HA (solid line), CHT/5HA (dashed line), and
CHT/10HA (dotted line) scaffolds. The rectangles present at
Figure 2a indicate the chosen regions for the integration
procedure used to obtain the images of Figure 3, each one
centered at the selected characteristic peak of chitosan
(1670 cm- 1) or HA (1045 cm- 1).
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lyzed (tens of microns). On the other hand, in CHT/10HA
scaffolds the quality of the blend was compromised. There
were more green and red areas, which correspond to CHT
and HA alone, respectively, and less yellow areas, which
correspond to the homogeneously blended biomaterials.
Mechanical properties. The mechanical properties of the
scaffolds in tissue engineering applications are of great im-
portance because of the necessity of structural stability to
withstand stresses incurred during in vitro culture and in vivo
implantation.31
Compressive mechanical tests were performed using
acellular scaffolds in dry and wet states. The compressive
modulus of the scaffolds is shown in Table 1. All samples
exhibited a sponge-like behavior. For both assays, the addi-
tion of HA in CHT networks reduced the mechanical
strength of the scaffold, while it increased its flexibility. This
behavior may essentially be due to the increase in pore size
by increasing the HA concentration. It was interesting to note
that CHT/1HA and CHT/5HA scaffolds had similar com-
pressive modulus in dry and wet states, probably because of
their similar pore network.
In addition to an increase in pore size, O’Brien et al.33 re-
ported a correlation between decreasing mechanical strength
and nonuniform pore shape in HA-based scaffolds. This may
explain the reason why CHT/10HA had a much lower
compressive modulus.
In the dry state, the compressive modulus of CHT/HA
scaffolds were lower but in the same order of magnitude
when compared with the modulus of articular cartilage re-
ported by Korhonen et al.34 The compressive modulus in wet
state was much lower compared with the dry state because
of HA’s ability of high water uptake. As CHT and HA are
two natural polymers, this drawback in terms of mechanical
strength was expected. However, the principal aim of in-
corporating HA into CHT scaffolds was to mimic the native
cartilage ECM. The compressive modulus may further im-
prove by the deposition of an ECM by chondrocytes in
CHT/HA scaffolds.
Swelling properties. Diffusion and exchange of nutrients
(e.g., oxygen) and waste throughout the entire scaffold are
related to the swelling properties of the scaffolds. Both CHT
and HA have an abundant number of hydrophilic groups,
such as hydroxyl, amino, and carboxyl groups, which can
promote water uptake in the structure.25 The swelling ability
was evaluated by soaking the scaffolds in PBS at 37C for 3
days (Fig. 4). The ratio between CHT and HA significantly
affected the scaffolds’ swelling properties. In the first 2 h, all
samples rapidly increased their weight. This rapid weight
increase continued until 8 h. Then, the swelling ratio of all
FIG. 3. Chemical maps obtained by FTIR microscopy of the cross sections of the scaffolds and pure HA: (a) CHT, (b) HA, (c)
CHT/1HA, (d) CHT/5HA, and (e) CHT/10HA. Green indicates the presence of CHT and red indicates the presence of HA.
The inset images individualize the presence of the pure polymers in the blends. The inset images next to (a) and (b) represent
the images control for HA and CHT, respectively. Color images available online at www.liebertonline.com/tec
FIG. 4. Swelling ratio of CHT and HA scaffolds in phos-
phate-buffered saline at 37C for 3 days. Values are reported
as mean – standard deviation (SD) (n = 3).
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samples seemed to stabilize, and a slight increase could be
observed with time. CHT scaffolds had the lowest values
during the entire experiment, whereas CHT/10HA had the
highest. CHT/1HA and CHT/5HA had similar swelling.
The swelling results indicated that HA incorporation can
greatly improve hydrophilicity and wetting of CHT scaf-
folds. Hence, scaffolds with higher content of HA showed
higher values of swelling. This aspect may imply that the
absorption and diffusion of solutes through the interior pores
in CHT scaffolds are greatly improved by incorporation of
low concentrations of HA.
In vitro enzymatic degradation. Scaffolds for tissue en-
gineering are usually required to either degrade or be re-
absorbed by the body after successful tissue regeneration.
CHT/HA scaffolds were incubated in a solution with lyso-
zyme and hyaluronidase or in a solution with PBS (control),
both at 37C for 7 and 14 days, to evaluate the weight de-
crease in the biopolymers due to enzymatic degradation. The
weight loss percentage of scaffolds as a function of incuba-
tion time is illustrated in Figure 5.
To distinguish between enzymatic degradation and sim-
ple dissolution, we compared the weight loss of samples that
had been placed in PBS (Fig. 5a) with those that had been
placed in PBS supplemented with lysozyme and hyaluroni-
dase at 7 and 14 days (Fig. 5b). According to Figure 5b, the
presence of HA rendered CHT scaffolds more susceptible to
enzymatic degradation, which is most likely due to higher
porosity and better accessibility of cleavage sites by the en-
zymes. The hydrophilicity of HA also contributed to a higher
degradation of CHT/HA scaffolds as it will enhance the
interaction of the biomaterial with the enzymatic solution.
After a high initial weight loss at day 7, the degradation rate
of the samples generally appeared to slow down at day 14,
which is most likely due to the gradual disappearance of
hexasaccharide sequences susceptible for enzymatic degra-
dation. The control experiment in PBS (Fig. 5a) showed that
practically none of the scaffolds degrade in PBS after 14 days.
The degradation of CHT has been already tested in several
in vitro studies.35–38 Most of these studies were, however,
performed at low pH for optimal lysozyme activity. In our
study, the enzymatic degradation experiments were per-
formed at higher pH, which resembles better degradation of
the scaffolds in physiological conditions. Hyaluronidase and
lysozyme concentrations used in this study (0.33 and 2 mg/
mL, respectively) are not representatives of their concentra-
tion in vivo. The largest single reservoir of hyaluronidase is
the synovial fluid of diarthrodial joints (0.5–4 mg/mL).39
Lysozyme commonly exists in various human body fluids
and tissues, with concentrations ranging from 4 to 13 mg/L
in serum40 and from 450 to 1230 mg/L in tears.41
In vitro articular bovine chondrocyte culture
Cell viability, proliferation, and adhesion studies on CHT/
HA scaffolds. In a live–dead assay, all materials exhibited
very good biocompatibility with hardly any detectable cell
death (Fig. 6). Further, cells were metabolically active (Fig. 7)
and well spread throughout the scaffolds in all formulations.
The presence of increasing concentrations of HA did not
influence cell loading of CHT scaffolds. This behavior is es-
sentially due to the low capacity for cell attachment of CHT.
The cell morphology and proliferation on CHT/HA scaf-
folds was further studied by SEM (Fig. 8). In all scaffolds,
chondrocytes were primarily localized in the superficial area
at days 1 and 3 and displayed a spherical morphology (cell
FIG. 5. Weight loss percentage of CHT/HA scaffolds as a function of incubation time (7 and 14 days) at 37C. Scaffolds
were embedded in (a) phosphate-buffered saline or (b) enzymatic solution containing both lysozyme and hyaluronidase.
Values are reported as mean– SD (n= 3).
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size diameter: *10 mm). At day 7, a limited increase in cell
number was observed but cells did not penetrate into the
scaffolds. At days 14 and 21, chondrocytes seeded in CHT/
5HA scaffolds significantly proliferated into the inner areas
of the scaffolds. In all scaffolds, even after 21 days of culture,
the cells continued to display a normal spherical morphol-
ogy, as observed in native cartilage.
Maintenance of chondrogenic phenotype. The round
shape of chondrocytes is an indicator of phenotype reten-
tion and is essential for matrix formation.42 The newly
formed matrix was stained with safranin-O (Fig. 9) and
alcian blue (Fig. 10), which showed GAG secretion. As HA
is a nonsulfated GAG, it stains blue in alcian blue staining.
Low amounts of HA in the scaffold can be easily distin-
guished from newly deposited ECM by the chondrocytes by
comparing alcian blue staining at 1 (Fig. 10A1–A35) with
staining at later time intervals. At day 1, chondrocytes did
not attach to the walls of CHT scaffolds, whereas in CHT/
HA scaffolds, the cells attached to walls, forming small
aggregates. At day 14, in CHT/5HA scaffolds (Fig. 9C14
and Fig. 10C14), it was interesting to note that most chon-
drocytes agglomerated to form very large aggregates ad-
herent to the scaffolds. The aggregates were located on the
superficial area. Hardly any penetration of cells in the
scaffolds was observed. These events were also reported by
Zhao et al.43 CHT/1HA and CHT/5HA showed enhanced
cell–material interactions and ECM production, with en-
hanced GAG production (Figs. 9 and 10). At day 35, CHT/
5HA scaffolds showed better cell dispersion and higher
ECM production and GAG deposition when compared with
the other formulations. Chondrocytes seeded in CHT scaf-
folds, even at day 35, remained in small aggregates (Fig.
9A35 and Fig. 10A35).
Enhanced cartilage tissue formation can be also qualita-
tively detected by SEM analysis (Fig. 11). At day 1, chon-
drocytes were in aggregates in all specimens, but at day 14
they were better spread and attached. At days 14 and 21,
improved chondrocyte dispersion could be noticed in CHT/
1HA and CHT/5HA scaffolds. In all specimens, lacunae
FIG. 6. Live–dead assay results of chondrocytes at passage 3 in proliferation medium seeded on CHT/HA scaffolds at days
1, 7, 14, and 21. Live cells were stained green by calcein and dead cells were stained red by ethidium (n = 3). Letters A–D
correspond to each of the four scaffold’s formulations, namely CHT, CHT/1HA, CHT/5HA or CHT/10HA, respectively. The
subscripts indicate the time period. Scale bar is 200 mm. Color images available online at www.liebertonline.com/tec
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FIG. 7. MTT assay results of chondrocytes at passage 3 in proliferation medium seeded on CHT/HA scaffolds at days 1, 7,
14, and 21 (n= 3). Metabolic active cells were stained dark purple. Letters A–D correspond to each of the four scaffold’s
formulations, namely CHT, CHT/1HA, CHT/5HA or CHT/10HA, respectively. The subscripts indicate the time period.
Original magnification is · 7.5. Scale bar is 3 cm. Color images available online at www.liebertonline.com/tec
FIG. 8. SEM micrographs (10 kV) of CHT/HA scaffolds seeded with articular bovine chondrocytes at passage 3 in pro-
liferation medium (n= 2). Letters A–D correspond to each of the four scaffold’s formulations, namely CHT, CHT/1HA, CHT/
5HA or CHT/10HA, respectively. The subscripts indicate the time period. Original magnification is · 500. Scale bar is 50mm.
Arrows point to chondrocytes and/or cartilage extracellular matrix deposition and stars indicate scaffold material.
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formation was seen in the matrix surrounding the chon-
drocytes. The morphology of these lacunas shows similari-
ties to natural cartilage.
Chondrogenic activity evaluation. It is known that when
chondrocytes maintain their natural spherical shape they
produce more GAGs and higher collagen type II versus
collagen type I ratio.44–46 Cell proliferation and ECM for-
mation were quantified by DNA and GAG assays, respec-
tively. In GAG quantification assay (Fig. 12a), the
incorporation of HA seemed to initiate an earlier GAG de-
position, particularly at day 14 for CHT/1HA and CHT/
5HA scaffolds. Results showed that the incorporation of HA
seemed to favor GAG deposition, because at day 35 all the
scaffolds containing HA had more GAG deposition when
compared with CHT scaffolds. For DNA quantification assay
(Fig. 12b), CHT/5HA had the highest amount of DNA at day
14. However, at day 35, CHT/1HA scaffolds significantly
supported a higher amount of cells when compared with
other formulations.
A higher value of GAG/DNA ratio indicates a higher
degree of differentiation of the cells.47 For GAG/DNA ratio
(Fig. 12c), at day 35, scaffolds with higher amount of HA
(CHT/5HA and CHT/10HA) induced a higher ratio. Al-
though CHT/1HA had the highest amount of cells in DNA
quantification, CHT/5HA had the highest GAG versus DNA
ratio. This may imply that CHT/5HA scaffolds are the for-
mulation that most favors cartilage ECM production, ren-
dering them attractive for cartilage TE.
Physicochemical effects of CHT/HA scaffolds
on cartilage regeneration
The key challenge for biomedical researchers is how to
design and control material properties to achieve a specific
biological response.48 It has been well established that the
physicochemical properties of materials can regulate bio-
logical responses, such as differentiation of stem cells,49
proliferation of fibroblasts,50 gene delivery,51 and cell
death.52
FIG. 9. Histological cross-sections show glycosaminoglycan (GAG) deposition (stained red) in CHT/HA scaffolds by
safranin-O staining at 1, 14, 21, and 35 days of chondrocyte culture in differentiation medium (n = 2). Letters A–D correspond
to each of the four scaffold’s formulations, namely CHT, CHT/1HA, CHT/5HA or CHT/10HA, respectively. Subscripts
indicate time intervals. Scale bar is 100mm. Color images available online at www.liebertonline.com/tec
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FIG. 10. Histological cross-sections show GAG deposition (stained blue) in CHT/HA scaffolds by alcian blue staining at 1, 14,
21, and 35 days of chondrocyte culture in differentiation medium (n= 2). Letters A–D correspond to each of the four scaffold’s
formulations, namely CHT, CHT/1HA, CHT/5HA or CHT/10HA, respectively. Subscripts indicate time intervals. Scale bar is
100mm. Color images available online at www.liebertonline.com/tec
FIG. 11. SEM micrographs (10 kV) of CHT/HA scaffolds seeded with articular bovine chondrocytes at passage 1 in dif-
ferentiation medium (n = 2). Letters A–D correspond to each of the four scaffold’s formulations, namely CHT, CHT/1HA,
CHT/5HA or CHT/10HA, respectively. The subscripts indicate the time period. Original magnification is · 500. Scale bar is
50 mm. Arrows point to chondrocytes and/or cartilage extracellular matrix deposition and stars indicate scaffold material.
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CHT/1HA and CHT/5HA scaffolds exhibited a uniform
pore network with high porosity (Fig. 1) and a homogeneous
polymer dispersion (Fig. 3), rendering them suitable for
bovine chondrocyte culture. The pore configuration allowed
cellular infiltration into the inner pores of the scaffolds
(Fig. 8). On the other hand, CHT and CHT/10HA scaffolds
had a very irregular pore network configuration with closed
pores. Consequently, in these scaffolds, the adhesion and
proliferation of chondrocytes were jeopardized when com-
pared with the other formulations. The scaffolds’ high water
uptake ability (Fig. 4) allowed the chondrocyte medium to
reach the interior pores of the scaffolds. Consequently, dif-
fusion and exchange of nutrients and waste throughout the
scaffolds were ensured, allowing cells to proliferate and be
metabolically active (Figs. 6 and 7).
Besides appropriate pore network and water uptake
ability, CHT/1HA and, especially, CHT/5HA had an im-
proved GAG dispersion and deposition (Figs. 9 and 10).
Additionally, the two referred formulations had similar
compressive modulus. Hence, physical and chemical factors
seem to simultaneously influence the biological outcome.
Cartilage regeneration seemed to be favored simultaneously
by chemical aspects, that is, intermediate amounts of HA (1%
and 5%), and also by physical aspects, that is, the referred
scaffold formulations also have similar compressive modu-
lus and a uniform pore network configuration. Therefore, in
this case scenario, it is not possible to distinguish case by case
the detailed mechanisms of how physical properties affect
the biological performance of the CHT/HA scaffolds. De-
spite this unclear contribution of each parameter, the results
obtained in our study are not compromised.
Conclusions
The incorporation of HA up to a concentration of 5% in
CHT scaffolds improved the physicochemical properties and
biological properties of CHT scaffolds. It enhanced pore net-
work configuration and increased pore size, swelling ratio,
and degradation rate when compared with pure CHT scaf-
folds. Higher concentrations of HA resulted in heterogeneous
blends with irregular and collapsed pore networks, particu-
larly CHT/5HA scaffolds favored chondrocyte adhesion, cell
FIG. 12. GAG and DNA assays on CHT/HA scaffolds at 1, 14, 21, and 35 days of culture: (a) GAG assay, (b) DNA assay, (c)
GAGs per DNA ratio. Values are reported as mean– standard deviation (n= 3). Significant differences for *p£ 0.05 and
**p£ 0.01 were found.
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proliferation, and cartilage matrix production when compared
with pure CHT scaffolds and other CHT/HA blends.
The biological outcome of CHT/HA scaffolds seems to be
influenced by physicochemical factors, such as polymer dis-
persion, pore network configuration, pore size, water uptake
ability, and mechanical strength. However, other studies are
required to elucidate case by case the dependence of biological
response on physical properties and to categorize the relative
weight of different physical and chemical factors.
Our results suggest that the freeze-dried scaffolds of CHT
and HA could have potential use in the regeneration of
cartilaginous lesions caused by various joint diseases, in-
cluding osteoarthritis and rheumatoid arthritis.
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